Europe Bovine Tuberculosis Diagnosis Market Size & Outlook
Europe bovine tuberculosis diagnosis market, 2018-2030 (US$M)
Related Markets
Europe bovine tuberculosis diagnosis market highlights
- The Europe bovine tuberculosis diagnosis market generated a revenue of USD 260.7 million in 2022.
- The market is expected to grow at a CAGR of 3.5% from 2023 to 2030.
- In terms of segment, traditional tests was the largest revenue generating test type in 2022.
- Molecular Diagnostic Tests is the most lucrative test type segment registering the fastest growth during the forecast period.
- Country-wise, Italy is expected to register the highest CAGR from 2023 to 2030.
Europe data book summary
| Market revenue in 2022 | USD 260.7 million |
| Market revenue in 2030 | USD 343.8 million |
| Growth rate | 3.5% (CAGR from 2022 to 2030) |
| Largest segment | Traditional tests |
| Fastest growing segment | Molecular Diagnostic Tests |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Serological Tests, Molecular Diagnostic Tests, Traditional Tests |
| Key market players worldwide | IDEXX Laboratories Inc, Zoetis Inc Class A, Thermo Fisher Scientific Inc, Asure Software Inc, Bio-Rad Laboratories Inc, BioNote, Enfer Medical, IDvet, PBD Biotech |
Other key industry trends
- In terms of revenue, Europe region accounted for 35.7% of the global bovine tuberculosis diagnosis market in 2022.
- Globally, Europe is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 162.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Bovine Tuberculosis Diagnosis Market Scope
Bovine Tuberculosis Diagnosis Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe bovine tuberculosis diagnosis market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bovine tuberculosis diagnosis market will help companies and investors design strategic landscapes.
Traditional tests was the largest segment with a revenue share of 59.61% in 2022. Horizon Databook has segmented the Europe bovine tuberculosis diagnosis market based on serological tests, molecular diagnostic tests, traditional tests covering the revenue growth of each sub-segment from 2018 to 2030.
The eradication of TB is a long term goal for the European Union (EU). However different epidemiological situations in the EU pose distinct difficulties that should be labeled with unique reinforcing measures.
For instance, certain farming practices and infection reservoirs in animal species sharing the environment with cattle can be a constraint to the progress Requirements of EU legislation in the context of the eradication programs are to be considered as the absolute minimum level of measures to be implemented.
Effective eradication programs include additional tailored measures aimed at addressing the different constraints to eradication in each epidemiological situation. Bovine TB caused by Mycobacterium bovis is a zoonotic disease, principally affecting livestock, which is of economic importance to the EU due to its impact on trade.
Reasons to subscribe to Europe bovine tuberculosis diagnosis market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe bovine tuberculosis diagnosis market databook
-
Our clientele includes a mix of bovine tuberculosis diagnosis market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe bovine tuberculosis diagnosis market , including forecasts for subscribers. This continent databook contains high-level insights into Europe bovine tuberculosis diagnosis market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe bovine tuberculosis diagnosis market size, by country, 2018-2030 (US$M)
Europe Bovine Tuberculosis Diagnosis Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
